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PURPOSE: To investigate whether caffeic acid phe-
nethyl ester (CAPE) and cortisone prevent prolifera-
tive vitreoretinopathy (PVR).
Methods: Twenty pigmented rabbits were used in this
study. All rabbits except controls received an intravi-
treal injection of 0.15 ml (75,000 U) of platelet-rich
plasma into their left eye. The animals were divided
into four groups: group I was treated with intraper-
itoneal injection of 0.5 ml (15 mmol/kg) of CAPE for 3
days, group II received 0.15 ml (4 mg/kg) of intravi-
treal cortisone, group III received nothing (blank
group), and group IV (control group) received only 1
ml of 1% ethanol intraperitoneally daily for 3 days.
Proliferative changes were graded in a masked fash-
ion by indirect ophthalmoscopy for a 15-day follow-
up period. The malondialdehyde (MDA), reduced
glutathione (GSH) and total nitrite (NO) levels were
measured in the vitreous humor.
Results: The grades of PVR were B 
/C in group I, and
C 
/D in group II. The PVR grade in the control group
was C 
/D. The mean MDA level in group I (4.09 /0.8
mmol/l) was significantly lower than in the blank
group (6.0 mmol/l) (p B/0.05). The mean GSH level in
group I (71.09 /11.2 mmol/l) was significantly differ-
ent than in the blank group (p B/0.05). The MDA and
GSH levels in group II were 4.79 /0.6 mmol/l and
53.89 /7.8 mmol/l, respectively. Both these levels
were not significantly different from the blank group
(p /0.05). The NO levels in both treatment groups
were significantly lower than in the blank group
(p B/0.001).
Conclusion: These findings suggest an inhibitory
effect of CAPE on PVR. The inhibitory effect was
supported by lower MDA and NO with higher GSH
levels in treatment groups than in the blank group.
There was no detected significant effect of cortisone
for preventing PVR experimentally.
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Introduction
Proliferative vitreoretinopathy (PVR) is a complex
process involving inflammation, migration and
proliferation of retinal pigment epithelial cells.
1,2
Several inflammatory cytokines and growth factors
are involved in these processes. PVR is the most
common cause of failure in the treatment of retinal
detachment and other vitreoretinal procedures. Pre-
vious studies have shown that different pharmacolo-
gic therapies may modify the proliferative process
and improve the success of surgery.
3,4 The migration
of retina pigment epithelial cells is an important step
in PVR. Therefore, blockage of the retina pigment
epithelial cell migration might be useful in preventing
proliferation.
Caffeic acid phenethyl ester (CAPE) is a potent
antioxidant agent produced by the hives of honeybee
propolis. It has antioxidant, antiproliferative, anti-
viral, antibacterial, cytotoxic anti-inflammatory, and
immunomodulator properties.
5 7 Most of these prop-
erties were attributed to two components of propolis,
which are CAPE and flavonoids. CAPE has also been
reported to inhibit the lipid peroxidation and the
growth of different types of abnormal transferred
cells. Therefore, we speculated that CAPE might
prevent PVR by its antiproliferative and antioxidant
effects.
Cortisone mainly suppresses intraocular inflamma-
tion in the body. Cortisone inhibits the expression of
vascular growth factors and angionetic cytokines and
contributes to the integrity of the blood /retina
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8 Our aim in this study was to investigate the
possible antiproliferative effects of CAPE and corti-
sone in the pathophysiology of experimental PVR.
Methods
Animals and experimental procedures
Twenty pigmented rabbits of either sex, weighing at
least 2 kg, were used in this experiment. All animals
were treated according to the ARVO Resolution on
the Use of Animals in Research. The rabbits except
controls were given intravitreal injections of 0.15 ml
(75,000 U) of platelet-rich plasma to the left eye. The
animals were divided into four groups: group I was
treated with intraperitoneal injection of 0.5 ml
(15 mmol/kg) of CAPE for 3 days, group II received
0.15 ml (4 mg/ml) of intravitreal cortisone, group III
received nothing (blank), and group IV (control
group) received only 1 ml of 1% ethanol intraper-
itoneally daily for 3 days. The eyes were examined by
ophthalmoscopy to assess the proliferation during a
15-day follow-up period. Proliferative changes were
graded in a masked fashion by indirect ophthalmo-
scopy. PVR was graded according to the classification
of the Retina Society.
9
Animals were anesthetized with an intramuscular
injection of ketamine hydrochloride (HCl) (30 mg/kg,
intramuscularly) and xylazine hydrochloride (5 mg/
kg, intramuscularly). Topical application of 0.5%
proparacaine hydrochloride was also used for local
anesthesia. Precautions were taken at the time of
each posterior chamber puncture to ensure that the
vitreous humor was not contaminated by bleeding
and to avoid contact with any structure of the
posterior chamber. The samples of vitreous humor
were collected and stored at  /408C until used to
measure the malondialdehyde (MDA), reduced glu-
tathione (GSH) and total nitrite (NO) levels. The
rabbits were then killed with an intravenous over-
dose of pentobarbital sodium for pathological exam-
ination.
MDA and GSH analysis
The MDA content was determined by the method of
Ohkawa et al.
10 That is, 0.2 ml of 8.1% sodium
dodecyl sulfate (SDS), 1.5 ml of 3 M acetate buffer
and 1.5 ml of 0.82% thiobarbituric acid were added in
succession to 0.25 ml of vitreous humor. The mixture
was cooled to room temperature, 0.5 ml of 35% SDS
was added and the tubes were heated as already
described for an additional 10 min. The mixture was
then cooled, centrifuged, and the optical density of
supernatant was read at 532 nm. The MDA concen-
trations in vitreous humor were expressed as micro-
moles per liter.
Reduced glutathione was estimated by Ellman’s
method.
11 That is, 0.5 ml of 10% trichloroacetic acid
solution was added to 0.5 ml of vitreous humor. A
protein-free supernatant was obtained by centrifuga-
tion. Four milliliters of 0.3 M Na2HPO4 and 0.5 ml of
5,5?-dithiobis (2-nitrobenzoic acid) were added to 0.5
ml of this supernatant. The intensity of the resulting
yellow color was read spectrophotometrically at 410
nm. The GSH concentrations were calculated by
comparing with the standard absorptions and were
expressed as micromoles per liter.
Total nitrite
Nitrate was reduced to nitrite by incubating 0.25 ml of
the collected vitreous humor for 60 min with 50 mU
of nitrate reductase, 200 mmol/l reduced nicotinamide
adenine dinucleotide phosphate and 10 mmol/l
flavine adenine dinucleotide. NO was then measured
by adding one volume of Griess reagent, prepared
before use by mixing equal volumes of 2% p-
aminobenzene sulfonamide in 5% phosphoric acid
and 0.2% N-(I-naphthyl)ethylenediamine dihy-
drochloride. The absorbance was read at 540 nm
against a sodium nitrate standard curve.
Statistical analysis
Statistical analysis was carried out using a non-
parametric test (analysis of variance) for comparison
of controls with experimental values at the different
times. pB/0.05 was considered statistically signifi-
cant.
Results
The grades of PVR were B /C and C /D in group I and
II, treated with with CAPE and cortisone, respec-
tively. The PVR grade in the blank group was C /D
(Fig. 1 and Table 1).
The mean MDA level in group I (4.09 /0.8 mmol/l)
was significantly lower than in the blank group (6.0
mmol/l) (pB/0.05). The mean GSH level in group I
(71.09 /11.2 mmol/l) was significantly higher than in
the blank group (48.5 mmol/l) (pB/0.05; Table 1).
The MDA and GSH levels in group II, who received
cortisone, were 4.79 /0.6 mmol/l and 53.89 /7.8 mmol/
l, respectively. Both these levels were not signifi-
cantly different from the blank group (p /0.05).
The mean vitreous concentration of NO in group I
was 5169 /76.1 mmol/l and in group II was 5019 /60.8
mmol/l. Both levels were significantly lower than in
the blank group (8379 /102.6 mmol/l) (pB/0.001)
(Table 1). There was no significant difference in
MDA, GSH, and NO levels between groups I and II
(p /0.05).
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Inflammation that increases the release of chemotac-
tic and mitogenic factors stimulates the proliferation.
Inflammation results in a decrease of GSH activity
and an increase in MDA content, thus confirming the
involvement of oxidative stress in the pathophsiology
of the process. Reactive nitrogen species, mainly NO,
play a role in inflammation. There is significant
increase in nitric oxide synthase (NOS) activity of
ocular tissues during the inflammatory process. NOS
is induced in many types of cells, including macro-
phages, neutrophils and vascular smooth muscles,
and is thought to be associated with some pathologic
conditions involving these cell types.
12 The inhibition
of NOS decreases tissue damage and inflammation.
NO levels in the vitreous humor of groups I and II
were significantly lower than the blank group. We
suggest that this reduced NO activity is due to
suppression of the inducible forms of NOS by CAPE
and cortisone. NO levels were positively correlated
with disease chronicity as well as plasma MDA levels.
Although NO is one of the well-known free radicals
in the body associated with oxidative stress, its role in
the etiopathogenesis of the PVR is still unclear.
CAPE and flavonoids are active components of
honeybee propolis extracts. Propolis is a natural
honey bee hive product. Both these compounds
FIG. 1. (a) Normal retinal structure is generally preserved except a focus composed of connective tissue in group I. Arrows
indicate collagen deposition (stain, Masson’s trichrome; original magniﬁcation, /50). (b) Normal structure is extensively
distorted with collagen deposition in group II eyes treated with cortisone. Arrows show collagen deposition (stain, Masson’s
trichrome; original magniﬁcation, /50). (c) The retina is replaced by connective tissue with large areas of collagen deposition
in the blank group. Arrows exhibite collagen deposition (stain, Masson’s trichrome; original magniﬁcation, /50). (d) Normal
retina in the control group (stain, Masson’s trichrome; original magniﬁcation, /50).
Table 1. PVR grades and MDA, GSH and NO levels in vitreous humor
Group MDA (mmol/l) GSH (mmol/l) NO (mmol/l) PVR grade
CAPE* 4.09 /0.8,B/0.05 71.09 /11.2,B/0.05 5169 /76.1,B/0.001 B /C
Cortisone** 4.79 /0.6, /0.05 53.89 /7.8, /0.05 5019 /60.8,B/0.001 C /D
Blank 6.09 /1.0 48.59 /11.3 8379 /102.6 D
Control 3.29 /1.5 95.79 /51.7 3899 /65.1  /
Data presented as mean9 /standard deviation, p value.
* Statistical values between group I and the blank group by analysis of variance.
** Statistical values between group II and the blank group by analysis of variance.
CAPE and cortisone in PVR
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antiviral, antioxidative, antimitogenic and to have
cytostatic activity.
5 7 CAPE inhibits both lipooxygen-
ase and cyclooxgenase pathways. Therefore, it might
contribute to the anti-inflammatory activity of propo-
lis. CAPE suppresses the proliferation and collagen
synthesis properly by reducing the reactive oxygen
intermediates; this is consistent with the antioxidant
property of CAPE.
13 CAPE may also exert its anti-
inflammatory effect by inhibiting the inducible NOS
expression.
14
Cortisone suppresses the activation and release of
various inflammatory mediators, including polymor-
phonuclear leukocytes, T lymphocytes, macrophages
and eosinophils. Macrophages produce different
angiogenetic cytokines such as interleukins and
tumor necrosis factor. Cortisone therefore has potent
angiogenetic properties. Cortisone suppresses arachi-
donic acid metabolism and maintenance of the
integrity of the cell membrane. It has also inhibits
growth factors that are part of the major stimulating
factors for development of PVR.
8 The anti-inflamma-
tory and immunosuppresive effects of corticosteroids
are related to inhibition of NOS induction. Cortisone
reduces the induction of NOS in many organs.
15 This
finding suggests that, in part, NO might be respon-
sible for tissue damage of the anti-inflammatory and
immunosuppressive actions of cortisone.
Various pharmacologic agents including 5-fluor-
ouracil, heparin, daunorubicin and cortisone have
been used against PVR.
16,17 The present study
investigated the therapeutic role of exogenous
CAPE and cortisone in the pathophysiology of
experimental PVR. Our results showed that CAPE
was effective at least partly in the development of
proliferation. This effect was associated with a
significant reduction of NO and MDA levels, while
increasing GSH levels. These results show that CAPE
protects GSH from oxidation in addition to less lipid
peroxidation with its potent antioxidant effect on the
vitreous humor. No significant therapetic effect of the
cortisone in the treatment of experimental PVR was
detected.
In conclusion, we investigated the preventive
effects of CAPE and cortisone in platelet-rich
plasma-induced PVR formation in rabbit vitreous
humor and found that CAPE is effective at least partly
in the inhibition of PVR experimentally. The clinical
results of both agents were correlated with NO, MDA
and GSH levels. These findings may encourage the
development of new studies designed to block the
inflammatory and proliferative response more speci-
fically and effectively.
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